Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats. Issue 5 (September 2015)
- Record Type:
- Journal Article
- Title:
- Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats. Issue 5 (September 2015)
- Main Title:
- Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats
- Authors:
- Wakabayashi, Keiichi
Hamada, Chieko
Kanda, Reo
Nakano, Takanori
Io, Hiroaki
Horikoshi, Satoshi
Tomino, Yasuhiko - Abstract:
- Background: Preventing peritoneal damage during peritoneal dialysis is critical. Reactive oxygen species (ROS) have an important role in peritoneal damage; however, few studies have investigated this. We aimed to determine the effects of oral astaxanthin (AST) supplementation in a peritoneal fibrosis (PF) rat model. Methods: Thirty-seven Sprague-Dawley rats were divided into 5 groups: Control 1 (fed a normal diet without stimulation), Control 2 (fed an AST-supplemented diet without stimulation), Group 1 (fed a normal diet with 8% chlorhexidine gluconate [CG] stimulation for 3 weeks), Group 2 (fed a 0.06% AST-supplemented diet with CG stimulation), and Group 3 (fed a 0.06% AST-supplemented diet that was initiated 4 weeks before CG stimulation). Peritoneal fibrosis, vascular proliferation, and fibrosis-related factor expression were examined. Results: Peritoneal thickness was significantly suppressed by AST supplementation. Astaxanthin diminished the number of CD68-, 8-hydroxy-2'–deoxyguanosine (8-OHdG)-, and monocyte chemoattractant protein-1 (MCP-1)-positive cells. Type 3 collagen, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and MCP-1 mRNA expression was significantly lower in Group 3 than in Group 1. Increased transforming growth factor-β (TGF-β) and Snail mRNA expression, vascular density, and the number of α–smooth muscle actin (α–SMA)-positive cells were also decreased in Group 3. Conclusion: Astaxanthin suppressed PF development through the inhibition ofBackground: Preventing peritoneal damage during peritoneal dialysis is critical. Reactive oxygen species (ROS) have an important role in peritoneal damage; however, few studies have investigated this. We aimed to determine the effects of oral astaxanthin (AST) supplementation in a peritoneal fibrosis (PF) rat model. Methods: Thirty-seven Sprague-Dawley rats were divided into 5 groups: Control 1 (fed a normal diet without stimulation), Control 2 (fed an AST-supplemented diet without stimulation), Group 1 (fed a normal diet with 8% chlorhexidine gluconate [CG] stimulation for 3 weeks), Group 2 (fed a 0.06% AST-supplemented diet with CG stimulation), and Group 3 (fed a 0.06% AST-supplemented diet that was initiated 4 weeks before CG stimulation). Peritoneal fibrosis, vascular proliferation, and fibrosis-related factor expression were examined. Results: Peritoneal thickness was significantly suppressed by AST supplementation. Astaxanthin diminished the number of CD68-, 8-hydroxy-2'–deoxyguanosine (8-OHdG)-, and monocyte chemoattractant protein-1 (MCP-1)-positive cells. Type 3 collagen, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and MCP-1 mRNA expression was significantly lower in Group 3 than in Group 1. Increased transforming growth factor-β (TGF-β) and Snail mRNA expression, vascular density, and the number of α–smooth muscle actin (α–SMA)-positive cells were also decreased in Group 3. Conclusion: Astaxanthin suppressed PF development through the inhibition of inflammation and oxidation in PF rats. It appears that the anti-oxidative agent AST may be useful for the prevention of peritoneal damage. … (more)
- Is Part Of:
- Peritoneal dialysis international. Volume 35:Issue 5(2015)
- Journal:
- Peritoneal dialysis international
- Issue:
- Volume 35:Issue 5(2015)
- Issue Display:
- Volume 35, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 35
- Issue:
- 5
- Issue Sort Value:
- 2015-0035-0005-0000
- Page Start:
- 506
- Page End:
- 516
- Publication Date:
- 2015-09
- Subjects:
- Anti-inflammation -- anti-oxidant -- astaxanthin -- peritoneal fibrosis
Peritoneal dialysis -- Periodicals
Continuous ambulatory peritoneal dialysis -- Periodicals
617.461059 - Journal URLs:
- http://www.pdiconnect.com/ ↗
https://journals.sagepub.com/home/ptd ↗ - DOI:
- 10.3747/pdi.2013.00317 ↗
- Languages:
- English
- ISSNs:
- 0896-8608
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 12490.xml